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The adhesion of human blood platelets 
onto vascular catheters was studied using a 
specially designed perfusion chamber. 
Polyurethane catheters were exposed to 
citrated human blood for different pe- 
riods (up to 20 min) and at different wall 
shear rates (190,260,330 sec- '). The rate 
of platelet adhesion was determined using 
"'In-labeled platelets, while the morphol- 
ogy of adhering platelets was inveshgated 
using scanning electron microscopy. A lin- 
ear increase in platelet adhesion was found 
within the first 10 min of perfusion, after 
which a plateau value was reached. The 
number of adhering platelets did not vary 
significantly with the shear rates applied, 
which may indicate that within the range of 
shear rates studied, the adhesion of plate- 
lets onto the catheter surface is mainly 
determined by the rate of the reaction 
between the platelets and the material sur- 
face. Catheters coated with a conjugate of 
heparin and albumin showed a four- to 
five-fold reduction in platelet adhesion as 
compared to uncoated catheters. This re- 
duction in platelet adhesion was not only 
due to the presence of albumin moieties at 
the surface but also to the presence of hepa- 
rin residues in the adsorbed albumin- 
heparin conjugate. 
INTRODUCTION 
Currently, intravascular catheters are widely applied in clinical practice, 
but thromboembolic  complication^,^-^ infections, and inflammatory re- 
sponses4 have been frequently reported. When indwelling catheters are 
used, the percentage of complications is increased ~ignificantly.~-~ 
Although the number of complications is certainly related to the experi- 
ence of the clinician introducing and positioning the catheters,' both physi- 
cochemical and mechanical properties of the catheters (surface roughness, 
chemical composition, surface charge, etc.)*-" are of major importance. 
The blood compatibility of intravascular catheters can be improved by 
immobilization of the anticoagulant heparin at the external surfaces.11-20 A 
promising approach for improving blood compatibility was reported by Hen- 
nink, et aL2' who used a covalently coupled albumin-heparin conjugate 
(alb-hep) combining the antithrombogenic properties of albumin" and hepa- 
rin. Physical adsorption of the conjugate onto different polymeric surfaces 
resulted in a substantial improvement of the blood compatibility of these 
materials in ziitro. 
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The use of flow devices for the investigation of blood-material interaction 
phenomena in vitro with a variety of both newly developed and commercially 
available polymeric materials has been reviewed by O l y ~ l a g e r . ~ ~  
Several investigators have emphasized the critical role of flow conditions 
for the in vitro examination of biomedical  material^.^^-^^ An increase in both 
thrombus formation and platelet adhesion onto a number of artificial sur- 
faces with increasing wall shear rate ( y w )  was observed. Baumgartner and 
Ha~denschild~’ devised an annular perfusion chamber to study the blood 
platelet interaction with subendothelium under flow conditions correspond- 
ing to those found in human veins and large arteries (vessel wall shear rates 
less than 800 sec-l). The same flow cell was used by Sakariassen28 to eluci- 
date the role of factor VIII-von Willebrand factor, in platelet adhesion onto 
human subendothelium in vitro. 
In our study, a modified Baumgartner cell was used to measure platelet 
adhesion onto polyurethane catheters as a function of both wall shear 
rate and perfusion time. In addition, the influence of albumin and alb-hep 
treatments of these catheters on platelet adhesion and morphology was 
investigated. 
MATERIALS AND METHODS 
Perfusion system 
The perfusion system used was similar to that described by Sakariassen 
et a1.28 The perfusate was circulated through an annular catheter cell using 
a nonocclusive peristaltic roller pump (VRE 200, Verder, Dtisseldorf, F.R.G.), 
while steady flow was obtained by means of gravity. A schematic drawing 
of the system is presented in Figure 1. 
The catheter cell, depicted in Figure 2, is a modification of the original 
Baumgartner cell. The most important changes concern the central rod of the 
chamber. Due to the reduced external diameter of this rod (0.d. 1.35 mm) it 
was necessary to replace the original rod material (PMMA) by stainless steel. 
Furthermore, an insertion block was introduced to ensure fixation of the 
catheters under flow conditions. The internal diameter of the PMMA-based 
flow chamber is 6.35 mm. 
Catheters 
All experiments were carried out with angiographic Ducor catheters (Cor- 
dis Europe, Roden, The Netherlands), which are polyesterurethane based 
(Estane, B. F. Goodrich Company, Akron, Ohio, U.S.A.). Thin-walled F7 
catheters ( id .  1.35 mm, O.D. 2.30 mm) were cut into pieces with a final 
length of 6.5 cm, tip closed and cleaned with Freon. Sterilization was per- 
formed with ethylene oxide. It should be emphasized that the results 
obtained with untreated Ducor catheters in this investigation cannot be used 
as a measure of the antithrombogenic properties of commercially available 
ADHESION OF BLOOD PLATELETS ONTO VASCULAR CATHETERS 615 
I 
L _ _ _ _ _ _ _ _ _ _ _ _ _ - _ - _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  J 
Figure 1. Schematic drawing of the perfusion system according to Saka 
riassen**: A = container with perfusate; B = roller pump; C = funnel; D = 
perfusion chamber; E = catheter; F = Silastic tubings. 
Cordis Ducor catheters because the commercial catheters are provided with 
an antithrombogenic coating, which was not used in this study. 
Albumin heparin conjugate treatment 
Heparin from porcine mucosa (160 U/mg, Diosynth, Oss, The Nether- 
lands) was covalently bound to albumin (Sigma A 954, St. Louis, MO) using 
a water-soluble carbodiimide as a coupling agent.29 The heparin was used as 
obtained without further fractionation with regard to molecular weight 
and/or AT I11 affinity. The treatment of each individual catheter with the 
albumin-heparin conjugate was achieved by incubation of the sterilized cathe- 
ter segments for 2 hr with a solution of alb-hep (5 mg/mL) in phosphate 
buffered saline (PBS), pH = 7.35. Subsequently a three-step rinsing proce- 
dure was carried out with PBS (each step consisting of a 10-min incubation 
with fresh PBS under static conditions) to remove the excess of alb-hep not 
firmly attached to the surface. Control experiments were carried out with 
albumin treated Ducor catheters, in which the catheters were treated with a 
5 mg/mL solution of albumin in PBS, while further preparation of the cathe- 
ters was similar to that used for the alb-hep-treated catheters. After the 
rinsing procedure, all catheters were kept in PBS until they were used in 
the perfusion experiments. 
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Figure 2. 
to it a catheter. 
Perfusion chamber (left). On the right the open chamber with next 
Perfusates 
Freshly drawn blood from healthy human donors who did not use drugs 
containing acetyl salicylic acid and/or oral contraceptives was anticoagulated 
with sodium citrate (1/10 vol, 3.8%). Then platelet labeling, washing, and 
resuspension of the different blood fractions was carried out according to 
SakariassenZ8 with the exception of the aspirin treatment. A final concen- 
tration of '"In-labeled platelets of 1.2 x 1O"/L was used, while 40% ( v / v )  of 
the perfusate consisted of red blood cells (RBC). The latter is in close agree- 
ment with average RBC concentrations found in whole human blood (hae- 
matocrit: 0.35-0.50). The contents of a single blood bag (= 500 mL citrated 
human blood) provided 15-25 perfusates of 15 mL each. 
"'Indium-labeled platelets and RBC-suspensions were mixed just before 
testing and incubated for 5 min at 37°C. 
Perfusions 
Perfusions with untreated catheters were carried out at three wall shear 
rates (190, 260, and 330 sec-') and six perfusion times (1, 3, 5, 7, 10, and 
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20 min). Shear rate variations were accomplished by adjusting the flow rate 
with the roller pump and the position of the funnel. A comparative study 
concerning platelet deposition onto untreated, albumin and alb-hep treated 
catheters was performed at one shear rate ( y 2 ,  = 330 sec-I), using the same 
perfusion times as mentioned above. 
All perfusion experiments were carried out at 37°C. Immediately after 
perfusion, the flow chamber was rinsed with 25 mL 10 mM HEPES-buffered 
saline, pH = 7.35, to remove all nonadhered blood constituents. The 
catheter was then removed from the flow chamber and placed in a 2.5% 
glutaraldehyde solution in PBS, which was used as a fixative for the surface- 
bound platelets. 
Determination of wall shear rate 
The wall shear rate at the catheter surface under controlled flow conditions 
in the catheter cell was calculated from the fluid dynamic equation derived 
by Bird et aL3': 
24 
nRi 
[2k/(l - k 2 ) ]  + [(ilk In k ) ]  
1 + k 2  + (1 - k2)/ln k y a  = - *  
where yu,  = the catheter wall shear rate (sec-'), Q = flow rate (cm3 sec-I), 
Xo = internal radius of the flow cell (cm), A, = (outer) radius of the catheter 
(cm), and k = R,/Xo. This relationship is valid for a fully developed (laminar) 
flow of a Newtonian fluid in the anulus. 
Since blood behaves Newtonian at shear rates >lo0 ~ e c - l , ~ ~  it is acceptable 
to use this equation for shear rate calculations in the catheter flow cell. 
Furthermore, Aarts et al.33 showed this assumption to be correct by 
Laser-Doppler velocimetry experiments using a flow chamber with a similar 
geometry. 
As a consequence of both the restricted flow rate capacity of the roller 
pump in the perfusion system described (max ca 150 cm3/min) and the 
dimensions of the catheter cell (internal diameter = 0.64 cm), a maximum 
wall shear rate at the catheter surface of 330 sec-' could be obtained 
( k  = 0.36). 
Determination of surface-bound platelets 
After perfusion, catheters were cut in five sections of 1.05-cm length each 
(surface area per segment: 0.726 cm') with a specially designed cutting knife, 
starting at the closed end of the catheters. The residual 1.25 cm was not used 
for further examination. Surface-bound radioactivity (expressed in cpm/cm2) 
was determined for all sections by means of a gamma counter (Trigamma 
600, Baird Atomic Inc., Bedford, MA). 
Specific platelet activity (cpm/platelet) was calculated from platelet counts 
(Thrombocounter, Coulter Electronics Ltd., Harpender, U.K.) and total 
radioactivity (cpm) of the final platelet resuspensions. The number of adher- 
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ing platelets per cm2 catheter surface was obtained by dividing surface bound 
radioactivity by the radioactivity per platelet. 
Morphological evaluation 
Glutaraldehyde fixation (one week) of the catheter segments was followed 
by a dehydration procedure using a series of ethanol-water mixtures (etha- 
nol contents: 25, 50, 75, and 100% (v/v), respectively, 5 min incubation with 
each solution), after which the samples were dried under flowing N2, glued 
to alumina discs and finally gold sputtered to achieve optimal resolution in 
the scanning electron microscopical analysis. The electron microscope used 
was an IS1 SS 40 (International Scientific Instruments Inc., Santa Clara, CA). 
Hemolysis and aggregation 
Hemolysis of red blood cells as a function of perfusion time was deter- 
mined by measuring the free hemoglobulin concentration spectrophoto- 
metrically at 567 nm (Ref. 34) after centrifugation (10 min at 2000g) of the 
perfusates. 
The influence of the washing procedure on platelet size distribution and 
ADP induced aggregation (final ADP concentration = 10 pM) was investi- 
gated with a blood cell analyzer (Baker Diagnostic Hematology Series 810, 
Baker Instruments, Bethlehem, PA) to ascertain that perfusions were carried 
out with blood samples containing functional platelets. 
RESULTS 
Influence of wall shear rate 
Platelet deposition onto untreated Ducor catheters ( n  = 100) at three dif- 
ferent wall shear rates (190, 260, and 330 sec-l) was measured as a function 
of perfusion time. The results are summarized in Figure 3. From the figure 
it appears that the adhesion of blood platelets onto Ducor catheters increases 
linearly with time during the first 10 min of perfusion, while plateau values 
(ca 15 x 10j plt/cm2) are found after 10 min of blood contact. With the three 
different wall shear rates used in the present study, no significant difference 
in platelet adhesion values were observed. 
Alb-hep treatment 
Preliminary adsorption studies using 125-Iodine labeled alb-hep (5 mg/mL 
in PBS) showed a surface concentration on Ducor catheters of 0.8 t 
0.4 pg/cm2 (f- s.d. ,  n = 8) after 2 h incubation under static conditions 
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Figure 3. 
perfusion time and shear rate: 0 = 190 sec-’, x = 260 sec--, (1 = 330 sec- 
Platelet deposition on Ducor catheter surfaces as a function of 
( t  = 20°C). This value is in close agreement with the results found for alb- 
hep adsorption onto a number of other polymeric n~aterials.~’ 
From desorytion experiments with perfusate under flow conditions 
( y U  = 330 sec-’), it appeared that after 20 min of perfusion, 25% of the 
amount of alb-hep initially present on the catheter was desorbed, probably 
by exchange with other plasma proteins. 
A comparative study with respect to platelet adhesion as a function of 
blood contact time was carried out for the untreated ( n  = SO), albumin 
( n  = 27), and alb-hep conjugate treated catheters ( 7 1  = 48) at a constant 
catheter wall shear rate ( y U  = 330 sec-’). The results, presented in Figure 4, 
show a strong reduction of the number of adhering platelets for the alb- 
hep-coated catheters as compared to the untreated catheters over the whole 
range of perfusion times examined. The platelet adhesion data for albumin- 
treated catheters are in between those found for the uncoated and alb-hep- 
coated catheters. Comparing albumin with alb-hep-coated surfaces this 
difference was significant for t = 20 min (Student’s t-test; 0.02 > p > 0.01). 
No significant difference was found when the results obtained with the 
albumin-coated catheters were compared with those of untreated catheters, 
Distribution of platelets 
The number of adhering platelets for catheter sections (1.05 cm) at various 
axial distances from the catheter tip were determined as a function of time. 
Average platelet adhesion numbers on a particular catheter segment as a 
function of time were calculated from data obtained in a series of experi- 
ments carried out at the same conditions. 
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Figure 4. Platelet deposition at constant shear rate (yU, = 330 sec-') on 
Ducor catheter surfaces as a function of perfusion time and surface treatment: 
o = untreated; x = albumin treated; 0 = alb-hep treated. 
In Figure 5 the results for alb-hep-coated and untreated catheters ( n  
values 4-16) are plotted for the six perfusion times used. A tendency for 
increasing platelet adhesion onto surfaces positioned at increasing dis- 
tance from the tip (along the flow direction) was only observed at longer 
perfusion times. 
Similar distribution patterns were observed either when experiments were 
carried out with untreated as well as treated catheters at yw = 190 sec-' and 
260 sec-l, nor when the catheters were coated with albumin. (Results not 
shown.) 
Morphological evaluation 
Microscopical analysis (SEM) of the platelets attached to both untreated 
and alb-hep-treated catheters did not show significant differences in mor- 
phology after 20 min perfusion. Most platelets were spread on the surface 
(spread conformation) while pseudopods were fully developed (see Fig. 6b 
and 6c). In addition, moderate amounts of small clusters of platelets 
(2-10 plts/cluster) were found regularly distributed over the surfaces (see 
Fig. 6a). Large aggregates could not be detected. 
Hemolysis and aggregation 
Both contact of the perfusate with foreign surfaces and air and the use of 
a peristaltic pump may induce damage of blood cells. Table I shows the 
free hemoglobin concentrations in the perfusates as a function of perfusion 
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Number of adhering platelets as a function of catheter position for Figure 5. 
different perfusion times (P.T.): c = untreated; B = alb-hep coated. 
time and shear rate. From this table it appears that a slight increase in free 
hemoglobin levels is observed with increasing perfusion times. 
Table I1 shows the results of ADP-induced aggregation of platelets in 
perfusates as a function of both shear rate and perfusion time. This table 
shows that ADP induced aggregation of platelets is substantially decreased 
as a function of perfusion time. 
We also studied the effect of washing and labeling procedures on platelet 
distribution and ADP-induced aggregation of platelets. Figure 7 and Table I11 
present the results. It appears that both the platelet distribution and the 
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Figure 6a. 
coated catheters. Perfusion time: 20 min; y w  = 330 sec-'. 
Representative SEM photograph of platelets adhered on un- 
Figure 6b. 
coated catheters. Perfusion time: 20 min; yrn = 330 sec-I. 
Representative SEM photograph of platelets adhered on un- 
ADP-induced aggregation were not significantly altered by the washing or 
labeling procedures. 
DISCUSSION 
Figure 4 shows that the deposition of platelets onto catheters pretreated 
with alb-hep is substantially reduced (four- to five-fold) as compared to that 
onto uncoated catheters, emphasizing the promising characteristics of this 
compound for improving the blood compatibility of biomaterials. 
For the adhesion of blood platelets onto foreign surfaces, two extreme 
cases can be distinguished. First, the adhesion of platelets is determined by 
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Figure 6c. 
coated catheters. Perfusion time: 20 min; yw = 330 sec-I. 
Representative SEM photograph of platelets adhered on alb-hep- 
TABLE I 
Hemoglobin Concentrations (% f SEM, n = 3-6) in Perfusate as a Function of 
Perfusion Time and Shear Rate after Perfusion. The Concentration after the Washing 
and Labeling Procedure (75 pg/mL f 12 pg/mL ( n  = 3)) was Taken as 100% 
Hemoglobin concentration (% * SEM) 
Perfusion Ym = yz, = Ym = 







151 ? 64 6 8 2  5 144 k 83 
60 f 33 125 + 28 179 t 61 
141 + 87 127 ? 36 161 ? 45 
77 f 20 167 ? 55 167 ? 31 
124 * 51 180 f 9 248 ? 17 
121 ? 51 237 * 57 264 ? 32 
TABLE I1 
ADP-Induced Aggregation of Platelets after Perfusion as a Function of Perfusion 
Time and Shear Rate Indicated as the Height of the Aggregation Curve 5 min after 
ADP Administration (% 2 SEM, n = 3-4 unless indicated otherwise). ADP 
Aggregation of Platelets after the Washing and Labeling Procedure was Taken as 100% 
Aggregation height (% ? S.E.M.) 
Perfusion Y U ,  = y.. = yur = 







115 ( n  = 1) 9 6 t  9 60 (n = 1) 
72 2 27 74 f 13 77 * 13 
38 ( n  = 1) 63 t 15 90 ( n  = 1) 
51 + 18 62 + 12 51 + 22 
3 0 +  4 35 ? 12 3 7 +  4 
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the washing and labeling procedure. 
ADP induced aggregation of platelets before (left) and after (right) 
the reaction rate of the platelets and the material surface; and second, this 
process is governed by the diffusion of the platelets from the bulk to the 
material surface.36 To be able to compare different materials with regard to 
platelet adhesion, this process should not be diffusion controlled. It is likely 
that our test system fulfils this requirement because an increased mass trans- 
fer of platelets (higher shear rate: higher diffusion coefficient of  platelet^^^), 
does not yield a higher platelet deposition rate. 
Another indication that platelet adhesion on our surfaces is not a diffusion 
controlled process is shown in Figure 5. The numbers of adhering platelets 
on different catheter segments are similar (or even increasing along the flow 
direction), For a diffusion-controlled process, a decrease in platelet adhesion 
numbers along the flow direction would be expected, due to the depletion 
of platelets in the boundary layer. 
These observations suggest that the adhesion of blood platelets on Ducor 
catheters under the test conditions applied is determined by the rate of 
reaction of platelets with the material surface. 
However, the range of the shear rate values appIied is somewhat narrow 
and additional studies are necessary to establish at which shear rate diffusion 
limited platelet adhesion will occur. 
TABLE 111 
Platelet Distribution in Platelet-Rich Plasma before 
and after Washing and Labeling Procedure 
Platelet distribution 
MPV Mode Medn 
(Pm3) PDW (/-4m3) (m3) 
Before 6.5 1.55 5.5 6.2 
After 6.5 1.56 5.0 5.9 
~ ~~ 
MVP = Mean platelet volume; PDW = Platelet distribution width; Mode = Platelet 
volume of the largest fraction; Medn = Platelet volume of the median fraction. 
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In order to perform reliable perfusion experiments it is necessary that 
the platelets used are equally reactive as platelets normally circulating in the 
bloodstream. Our results show that after the washing and labeling proce- 
dures, neither spontaneous platelet aggregation nor changes in reactivity of 
the platelets toward ADP (Fig. 7) were observed. 
These results suggest that the function of the platelets used was the same 
as that of nontreated platelets. Since the perfusate is recirculated, it can also 
be expected that some damage to blood elements will occur. Table I shows 
that a maximum concentration of free hemoglobin of 198 pg/mL was mea- 
sured after 20 min perfusion, corresponding with a hemolysis of only 
0.2%. On the other hand, Table I1 shows that a substantial decrease in the 
function of platelets occurred, as indicated by the ADP-induced aggregation. 
Therefore perfusion times were limited to 20 min. 
From the observation that albumin-coated catheters showed higher platelet 
adhesion numbers than alb-hep-coated ones (see Fig. 4), it can be concluded 
that the reduction in numbers of adhering platerets onto alb-hep-coated 
catheters cannot only be ascribed to the presence of albumin moieties of the 
conjugate at the surface. This was also concluded from a previous study in 
which another type of test system was applied and dog blood instead of 
human blood was used as a source of platelets.23 
Scanning electron microscope photographs reveaIed that after 20 min 
perfusion, clusters of blood platelets with fully developed pseudopods are 
present on uncoated catheters (Fig. 6a). This suggests that the platelet re- 
lease reaction has taken place3’ in which platelet aggregating constituents 
have been released (e.g., ADP).38 
Figure 6c shows that platelets adhering onto alb-hep conjugate coated 
catheters have a similar shape as those adhered onto noncoated catheters 
(see Fig. 6b). In addition, platelet aggregates, as present on uncoated cathe- 
ters, were also observed on alb-hep-coated catheters. 
In conclusion, although platelet adhesion is only one of the parameters 
needed to assess the bIood compatibility of surfaces, the test system 
described in this paper provides a useful tool for the estimation of the 
thrombogenicity of catheter surfaces in uitro and hopefully can be useful for 
predicting the performance of the catheters in uiuo. From experiments using 
alb-hep-coated catheters, it was found that this coating substantially 
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